Amgen Inc.
AMGN
$311.29
$32.9011.82%
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 19.62% | -2.02% | |||
| Total Other Revenue | 2.25% | 17.16% | |||
| Total Revenue | 18.73% | -1.19% | |||
| Cost of Revenue | 72.41% | -0.44% | |||
| Gross Profit | -0.27% | -1.45% | |||
| SG&A Expenses | 69.70% | 3.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 6,988.89% | -115.79% | |||
| Total Operating Expenses | 78.60% | -1.06% | |||
| Operating Income | -75.15% | -1.39% | |||
| Income Before Tax | -56.24% | 20.63% | |||
| Income Tax Expenses | -60.83% | -7.66% | |||
| Earnings from Continuing Operations | -55.66% | 25.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -55.66% | 25.45% | |||
| EBIT | -75.15% | -1.39% | |||
| EBITDA | -42.84% | -1.08% | |||
| EPS Basic | -55.67% | 25.45% | |||
| Normalized Basic EPS | -95.80% | 155.63% | |||
| EPS Diluted | -55.75% | 25.29% | |||
| Normalized Diluted EPS | -95.82% | 155.16% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.37% | 0.19% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 1.26% | -0.20% | |||
